Status:
COMPLETED
Retrospective Analysis of the Efficacy of Morphine Gel to Treat Pain Associated With Perineal RadioDermatitis
Lead Sponsor:
Institut Curie
Conditions:
Dermatitis, Radiation Induced
Eligibility:
All Genders
18-100 years
Brief Summary
Retrospective study evaluating the efficacy of a pharmacy-prepared Morphine gel used in clinics for the treatment of pain associated with perineal radiodermatitis. The main aim of this study is to eva...
Detailed Description
Radiotherapy (RT) can induce acute side effects or toxicities, known as radiodermatitis (RD). Technological and technical advances have made it possible to reduce these toxicities (1), although certai...
Eligibility Criteria
Inclusion
- Patients 18 years and older;
- Use of a local analgesic treatment based on Morphine gel for pain associated with perineal radiodermatitis.
- Patients not relieved by prescribed systemic treatments (per-os or intravenous)
- Patients treated with radiotherapy for a perineal tumor, whether or not associated with medical treatment such as chemotherapy.
- Minimum grade of radiodermatitis: Grade II
Exclusion
- Patients who have not used the prescribed morphine gel
- Minor patients
- Patients using morphine gel for wounds other than radiodermatitis
- Patients who object to the re-use of their data
Key Trial Info
Start Date :
December 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2024
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT07207889
Start Date
December 1 2024
End Date
December 31 2024
Last Update
October 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut Curie
Paris, France, 75248